The transaction, structured as a securities purchase agreement with a fundamental institutional investor, involves the sale of 5.9 million shares. Abundia expects the offering to yield gross proceeds of $20 million, though the final net figure will depend on the deduction of offering expenses. The deal is slated to close on Monday, contingent upon the satisfaction of customary closing requirements.
Strategic Capital Allocation
Management intends to utilize the capital infusion to strengthen the company’s financial position and support long-term infrastructure goals. According to the announcement, the funds are earmarked for several key priorities:- Significant reduction of existing corporate debt.
- The commencement of construction on a new innovation hub.
- General working capital and ongoing corporate purposes.

Comments (0)
No comments yet. Be the first!